Impact of the mental health and dynamic referral for oncology (MHADRO) program on oncology patient outcomes, health care utilization, and health provider behaviors: A multi-site randomized control trial.

The trial did not show a benefit on the primary mental-health outcome. Secondary referral and utilization findings are weaker. Providers did not consistently receive and review the reports before seeing patients. The authors state this likely diluted the intervention. The sample was disproportionately white women diagnosed with breast cancer. Results may not apply to other cancer populations. Only 50 patients accepted a dynamic referral. This small subgroup limits confidence in findings about referral acceptance. The patient report was reviewed by research assistants rather than providers. The authors state this may have reduced its importance to patients. The article gives follow-up timing inconsistently. It says 2, 6, and 12 months in one place and 3, 6, and 12 months in another. The supplied text does not provide the chart review counts or rates behind the reported significant provider documentation and utilization results.

The article is tagged as NIH extramural research support. The supplied text does not include a conflict-of-interest declaration.

Do not conclude that MHADRO improves cancer patients' mental health because referral uptake or chart documentation changed. The main mental-health outcome was null for the whole sample and for the most distressed patients, and referral findings come from a small subgroup that already had worse symptoms when they accepted.